CI Select 100e Managed Portfolio Corporate Class
Series F USDFund overview
This fund invests its assets in mutual funds that invest primarily in equity securities.
Fund details
| Inception date | November 2006 |
|
CAD
Total net assets ($CAD)
As at 2024-12-30
|
$101.6 million |
|
NAVPS
As at 2025-01-31 |
$15.3697 |
|
MER (%)
As at 2024-09-30 |
1.39 |
| Management fee (%) | 1.00 |
| Asset class | Asset Allocation |
| Currency | USD |
| Minimum investment | $500 initial/$25 additional |
| Distribution frequency | Quarterly |
| Last distribution | $0.0801 |
Risk rating1
- Low
- Low to medium
- Medium
- Medium to high
- High
Performance2 As at 2025-01-31
Growth of $10,000 (Since inception date)
Calendar year performance
average annual compound returns
| YTD | 1 Mo | 3 Mo | 6 Mo | 1 Y | 3 Y | 5 Y | 10 Y | Inception* |
|---|---|---|---|---|---|---|---|---|
| 17.37% | -1.47% | 2.75% | 7.73% | 17.37% | 5.43% | 7.97% | 6.02% | 4.35% |
Distribution history3
| Payable date | Total |
|---|---|
| 2024-03-22 | 0.0801 |
| 2023-03-24 | 0.1001 |
| 2022-12-16 | 0.0617 |
| 2022-09-23 | 0.0625 |
| 2022-06-24 | 0.0659 |
| Payable date | Total |
|---|---|
| 2022-03-25 | 0.6742 |
| 2021-03-26 | 0.2108 |
| 2020-12-18 | 0.0563 |
| 2020-09-25 | 0.0495 |
| 2020-06-26 | 0.0394 |
Management team
|
Alfred Lam
Stephen Lingard
|
Note: This page is not complete without disclaimers on the next page.
CI Select 100e Managed Portfolio Corporate Class
Series F USD- US Equity 44.19
- International Equity 29.35
- Canadian Equity 12.25
- Other 5.31
- Commodities 2.92
- Cash and Equivalents 2.23
- Foreign Government Bonds 1.83
- Foreign Bonds - Funds 1.74
- Income Trust Units 0.18
- Technology 33.64
- Exchange Traded Fund 18.37
- Other 11.13
- Financial Services 9.33
- Healthcare 8.66
- Mutual Fund 5.32
- Basic Materials 3.90
- Consumer Services 3.60
- Fixed Income 3.57
- Consumer Goods 2.48
- United States 45.91
- Other 23.79
- Canada 14.42
- Multi-National 7.06
- Japan 2.49
- Taiwan 2.03
- Cayman Islands 1.59
- United Kingdom 1.17
- Israel 0.88
- Netherlands 0.66
|
Underlying fund allocations
|
Sector | (%) |
|---|---|---|
| 1. CI Global Alpha Innovators Corporate Class I | Mutual Fund | 36.33% |
| 2. Ci Global Artificial Intelligence Etf | Exchange Traded Fund | 16.92% |
| 3. CI Munro Global Growth Equity Fund Series I | Mutual Fund | 6.34% |
| 4. Ci Private Market Growth Fund (Series I | Mutual Fund | 5.32% |
| 5. CI Select U.S. Equity Managed Fund Class I | Mutual Fund | 5.29% |
| 6. CI Global Health Sciences Corporate Class I | Mutual Fund | 4.91% |
| 7. CI Select Canadian Equity Managed Fund Class I | Mutual Fund | 4.82% |
| 8. Global X Equal Weight Canadian Bks Ind ETF (HBNK) | Exchange Traded Fund | 2.97% |
| 9. CI Japan Equ Idx ETF Non-Hgd (JAPN.B) | Exchange Traded Fund | 2.49% |
| 10. iShares 20 Plus Year Treasury Bond ETF (TLT) | Fixed Income | 1.85% |
| 11. Ci Private Markets Income Fund (Series I) | Fixed Income | 1.74% |
| 12. CASH | Cash and Cash Equivalent | 1.69% |
| 13. CI Gold+ Giants Covered Call ETF(CGXF) | Exchange Traded Fund | 1.68% |
| 14. VanEck Gold Miners ETF (GDX) | Exchange Traded Fund | 1.54% |
| 15. CI Canadian Banks Covered Call Inc Class ETF (CIC) | Exchange Traded Fund | 1.49% |
|
Top holdings
|
Sector | (%) |
|---|---|---|
| 1. Ci Global Artificial Intelligence Etf | Other | 16.92% |
| 2. Ci Private Market Growth Fund (Series I | Other | 5.32% |
| 3. NVIDIA Corp | Computer Electronics | 3.82% |
| 4. Microsoft Corp | Information Technology | 3.22% |
| 5. Broadcom Inc | Computer Electronics | 2.61% |
| 6. Amazon.com Inc | Retail | 2.30% |
| 7. CASH | Cash and Cash Equivalent | 2.28% |
| 8. Apple Inc | Computer Electronics | 1.89% |
| 9. Ci Private Markets Income Fund (Series I) | Other | 1.74% |
| 10. Meta Platforms Inc Cl A | Information Technology | 1.74% |
| 11. Taiwan Semiconductor Manufactrg Co Ltd - ADR | Computer Electronics | 1.73% |
| 12. Gold Bullion | Other | 1.49% |
| 13. SPDR S&P Biotech ETF (XBI) | Exchange Traded Fund | 1.45% |
| 14. Galaxy Digital Holdings Ltd | Asset Management | 1.44% |
| 15. Eli Lilly and Co | Drugs | 1.44% |
Note: This page is not complete without disclaimers on the next page.
1 The risk level of a fund has been determined in accordance with a standardized risk classification methodology in National Instrument 81-102, that is based on the fund’s historical volatility as measured by the 10-year standard deviation of the fund’s returns. Where a fund has offered securities to the public for less than 10 years, the standardized methodology requires that the standard deviation of a reference mutual fund or index that reasonably approximates the fund’s standard deviation be used to determine the fund’s risk rating. Please note that historical performance may not be indicative of future returns and a fund’s historical volatility may not be indicative of future volatility.
2 Commissions, trailing commissions, management fees and expenses all may be associated with mutual fund investments. Please read the prospectus before investing. The indicated rates of return are the historical annual compounded total returns net of fees and expenses payable by the fund (except for figures of one year or less, which are simple total returns) including changes in security value and reinvestment of all dividends/distributions and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any securityholder that would have reduced returns. Mutual funds are not guaranteed, their values change frequently, and past performance may not be repeated.
3 Please refer to the fund’s simplified prospectus for distribution information.
4 Portfolio allocations will fluctuate over the life of the mutual fund as the portfolio holdings and market value of each security changes. The portfolio manager(s) may change the portfolio allocations in some or all of the sectors.
The contents are not to be used or construed as investment advice or as an endorsement or recommendation of any entity of security discussed.
Certain statements contained in this communication are based in whole or in part on information provided by third parties and CI has taken reasonable steps to ensure their accuracy.
The rates of return are used only to illustrate the effects of the compound growth rate and are not intended to reflect future values or returns on investment in an investment fund.
The “Growth of $10,000 invested” chart shows the final value of a hypothetical $10,000 investment in securities in this class/series of the fund as at the end of the investment period indicated and is not intended to reflect future values or returns on investment in such securities.
Management Expense Ratio (“MER”) represents the trailing 12-month management expense ratio, which reflects the cost of running the fund, inclusive of applicable taxes including HST, GST and QST (excluding commissions and other portfolio transaction costs) as a percentage of daily average net asset value the period, including the fund’s proportionate share of any underlying fund(s) expenses, if applicable. The MER is reported in each fund’s Management Report of Fund Performance (“MRFP”). MRFPs can be found within the Documents tab on ci.com.
CI Global Asset Management is a registered business name of CI Investments Inc. ©CI Investments Inc. 2025. All rights reserved.
Published January 2025